Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Developmental, Psychosocial and Learning Problems

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 14.3%Moderate 6 · 85.7%High 0 · 0%

ABC ‐ Irritability subscale Mean score changes 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 308 participants
Moderate

ABC ‐ Hyperactivity subscale Mean score changes 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 308 participants
Moderate

ABC ‐ Stereotypy subscale Mean score changes 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 308 participants
Moderate

Weight gain 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 308 participants
Moderate

Sedation 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 313 participants
Moderate

Tremor 8 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 313 participants
Moderate

Relapse rate 16 weeks of treatment · children/youth with ASD

1 finding from 1 review

Aripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 85 participants
Low